Literature DB >> 26995131

Colostrum and milk pasteurization improve health status and decrease mortality in neonatal calves receiving appropriate colostrum ingestion.

Ramon Armengol1, Lorenzo Fraile2.   

Abstract

The objective of the study was to evaluate if on-farm heat treatment of colostrum and bulk tank milk can improve calf health status and morbidity and mortality rates during the first 21d of life in neonatal Holstein calves receiving appropriate colostrum ingestion. A total of 587 calves were randomly assigned to 2 groups of males and females over 18mo. The nonpasteurized group (n=287, 143 males and 144 females) was fed frozen (-20°C) colostrum (6-8L during the first 12h of life) that was previously reheated up to 40°C. They were also fed refrigerated (4°C) raw milk from the bulk tank that was also reheated up to 40°C (1.8L every 12h). The pasteurized group (n=300, 150 males and 150 females) was also fed colostrum and milk, but both were pasteurized before freezing. Blood samples were drawn from all calves to obtain serum at 2 to 5d of life. Serum total protein (g/dL) was determined using a commercially available refractometer. Colostrum and milk underwent routine bacteriological analysis to determine total plate counts (cfu/mL) and total coliform counts (cfu/mL). All the calves underwent clinical examination every 24h during the first 21d of life. Every day, calves were clinically diagnosed either as being healthy or suffering from respiratory disease, neonatal calf diarrhea, or suffering other diseases. On-farm heat treatment for colostrum and milk reduced total plate counts and total coliform counts between 1 and 2 log10. Pasteurization of colostrum and milk significantly decreased the morbidity and mortality (5.2 and 2.8%) in comparison with calves receiving nonpasteurized colostrum and milk (15.0 and 6.5%), respectively, during the first 21d of life, even in animals receiving appropriate colostrum ingestion.
Copyright © 2016 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  colostrum; health status; milk; on-farm heat treatment

Mesh:

Year:  2016        PMID: 26995131     DOI: 10.3168/jds.2015-10728

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  The Specific Immune Response after Vaccination against Neonatal Calf Diarrhoea Differs between Apparent Similar Vaccines in a Case Study.

Authors:  Román Gonzalez; Laura Elvira; Carlos Carbonell; Geert Vertenten; Lorenzo Fraile
Journal:  Animals (Basel)       Date:  2021-04-25       Impact factor: 2.752

2.  Management factors associated with bovine respiratory disease in preweaned calves on California dairies: The BRD 100 study.

Authors:  G U Maier; W J Love; B M Karle; S A Dubrovsky; D R Williams; J D Champagne; R J Anderson; J D Rowe; T W Lehenbauer; A L Van Eenennaam; S S Aly
Journal:  J Dairy Sci       Date:  2019-06-13       Impact factor: 4.034

3.  Quantitative Analysis of Colostrum Bacteriology on British Dairy Farms.

Authors:  Robert M Hyde; Martin J Green; Chris Hudson; Peter M Down
Journal:  Front Vet Sci       Date:  2020-12-07

4.  Influence of first colostrum pasteurization on serum immunoglobulin G, iron, and activity of gamma-glutamyltransferase in newborn dairy calves.

Authors:  Sebastian Ganz; Klaus Failing; Abdulwahed Ahmed Hassan; Michael Bülte; Axel Wehrend
Journal:  Vet World       Date:  2021-08-29

5.  Prevalence of respiratory bacterial pathogens and associated management factors in dairy calves in Taiwan.

Authors:  Hsu-Hsun Lee; Natcha Thongrueang; Shyh-Shyan Liu; Huan-Yu Hsu; Yi-Lun Tsai
Journal:  J Vet Med Sci       Date:  2022-06-08       Impact factor: 1.105

Review 6.  Production of Bovine Colostrum for Human Consumption to Improve Health.

Authors:  Merve Kaplan; Ayşenur Arslan; Hatice Duman; Melda Karyelioğlu; Barış Baydemir; Bilgetekin Burak Günar; Merve Alkan; Ayşe Bayraktar; Halil İbrahim Tosun; Melih Ertürk; Günay Eskici; Rebbeca M Duar; Bethany M Henrick; Steven A Frese; Sercan Karav
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.